Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis.

AUTOR(ES)

Dhingra, R K

RESUMO

Pneumoccal cell wall and capsular products from eight serotypes were tested for their ability to inhibit polymorphonuclear neutrophil killing of the same eight pneumococcal strains. Crude pneumococcal cell wall preparations from all serotypes inhibited phagocytic killing of several pneumococcal serotypes, and were just as effective with heterologous as with homologous strains. Phagocytosis dependent on heat-labile serum factors was inhibited, whereas phagocytosis not dependent on heat-labile factors was not significantly affected. These findings were compatible with inhibition of complement consumption. The inhibitory activity was found in a purified cell wall mucopeptide, whereas purified capsular polysaccharides failed to inhibit phagocytosis.

Documentos Relacionados

• Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.
• Inhibitory effects of anticardiolipin antibodies on lymphocyte proliferation and neutrophil phagocytosis.
• Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.
• The Photoelectric Titration of Pneumococcal Capsular Polysaccharide
• Correlation of Circulating Capsular Polysaccharide with Bacteremia in Pneumococcal Pneumonia